How to view the first quarter transcript of the pharmaceutical equipment industry? The industry says

Pharmaceutical Network Market Analysis: Into April, listed companies in the first quarter of the quarter of the earnings forecast has been disclosed one after anotherFrom the disclosed enterprise situation, the first quarter of the industry is difficult, some pharmaceutical machine enterprises due to downstream enterprises to resume production delay, pharmaceutical enterprises delayed delivery and other factors, resulting in the company's equipment delivery and commissioning progress slowed down, the current period sales revenue significantly reduced, the current net profit fell sharply"In the short term, enterprises can not fully resume production, coupled with the company's downstream customers because of the delay in picking up goods, many enterprises' business activities have been affected, operating income decreased year-on-year"There are drug machine people as expressedHow to view the first quarter transcript of the pharmaceutical equipment industry? (Source: Pharmaceutical Network) Short-term - the business climate of the industry is still relatively high, but not all pharmaceutical companies are facing this problem, many pharmaceutical equipment companies in the first quarter of the performance is relatively optimisticFor example, Dongfulong expects net profit attributable to shareholders of listed companies to rise 190%-220% year-on-year to 46.1956 million yuan-50.974 4 million yuan in the first quarterIn response to the reasons for the increase in net profit, the company said that the beginning of the reporting period, continuing last year's development trend, pharmaceutical equipment sector and medical equipment sector revenue increased from a year earlierDuring the reporting period, the company to do a good job in epidemic prevention work at the same time, actively resume production and work, reduce the impact of the epidemic on the company, cost control is good
Canaan Technology expects net profit attributable to shareholders of listed companies to increase 60% to 90% year-on-year in the first quarter, with a profit of RMB5.551 million - RMB659.19 millionThe company said that although the delay in the resumption of work has caused some impact on production and operation, but some downstream customers pharmaceutical enterprises and logistics industry resumed production in advance, in order to meet customer demand, the company to do a good job in the prevention and control of the epidemic at the same time, strengthen customer communication, serious study of work deployment, actively respond to and help customers speed up the resumption of production, to ensure stable growth in business performance
In addition, from the order situation, the first quarter of most pharmaceutical machine enterprises are relatively full of ordersFor example, Chutian Technology said that although the first quarter revenue and net profit are down, but the company adopted telecommuting, sales, online services and other models, the first quarter of new orders increased by 20% compared to the same period last year, in the hands of orders sufficient;
The change of performance, to a certain extent, reflects the business climate of the industryIt is not difficult to see that the first quarter of the pharmaceutical equipment industry market climate is still relatively highThe industry believes there are several factorsAmong them, from a market point of view, in the first quarter, some drugs due to the expansion of production capacity, in order to meet the market supply, the demand for related pharmaceutical equipment continues to expand From the corporate point of view, pharmaceutical equipment enterprises good cost control, as well as active communication with downstream customers to ensure the successful completion of current delivery, is some enterprises in the first quarter to achieve performance growth of an important factor
In the long run - industry opportunities and challenges coexist because many industries have a strong seasonal performance, some enterprises may be a loss or a small profit in the first two or three quarters, but the end of the year performance is reflected, even the industry's high business climate of enterprises are also facing the problem of customer checkout time difference The industry believes that the development of the pharmaceutical equipment industry needs to be viewed in the medium to long term
In the medium term, with the industry enterprises to resume production gradually resumed, operating production gradually stabilized, in the case of sufficient orders, the industry generally has confidence in the pharmaceutical equipment industry in 2020 sales And in the long run, medicine is just in demand, pharmaceutical equipment industry as the pharmaceutical industry upstream, facing a great opportunity At present, China's pharmaceutical equipment industry has formed a complete category, independent and complete industrial system, the number of enterprises, small scale, distribution, low level, market chaos is gradually improving the situation, the concentration of the industry is constantly improving, and in the low-end market has basically achieved import substitution
Of course, the challenges are side-by-side With the continuous promotion of policies such as band procurement, new medical insurance, and consistency evaluation, the pharmaceutical industry has also put forward higher requirements for pharmaceutical equipment while innovating and upgrading The industry believes that, as the pharmaceutical industry's "mother machine", the technical level of pharmaceutical equipment determines the level of pharmaceutical, so pharmaceutical companies need to continue to strengthen research and development investment, continuous innovation
It is worth mentioning that in recent years, with the pharmaceutical equipment industry favorable policies, as well as the related standard system revision work, for the domestic pharmaceutical equipment high-quality development released a positive signal, to domestic pharmaceutical machine enterprises to boost the development of confidence, more and more powerful pharmaceutical machine enterprises pay more attention to the "quality" of the promotion and product technology innovation
In March 2019, seven revisions of the industry standard system for pharmaceutical equipment, such as the Pharmaceutical X-ray Foreign Body Detector, and the revision of the four pharmaceutical equipment industry standards of the "Collecting Devices", "Pharmaceutical Air Flow Mixers", "Daihoney Pill Machines" and "Whole Grain Machines" were completed by the end of 2019; The completion period is 2021
With the implementation of these industry standards, pharmaceutical enterprises will have new standard reference, better towards a high level of progress, but also will accelerate the pace of import substitution of high-quality products.